Stages of progression in drug abuse involvement across generations in Jeddah, Saudi Arabia

Neurosciences

Volumn 13, Issue 1, 2008, Pages 37-40

  Bassiony, Medhat M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALCOHOL ABUSE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ABUSE; DRUG DEPENDENCE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; SAUDI ARABIA; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; TOBACCO;

EID: 38349107881     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kandel DB, Yamaguchi K. Stages of drug involvement in the U.S. population. In: Kandel DB, editor. Stages and pathways of drug involvement: examining the gateway hypothesis. New York (NY): Cambridge University Press; 2002. p. 65-89.
2. Fergusson DM, Boden JM, Horwood LJ. Cannabis use other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006; 101: 556-569.
3. Heckman JJ. The scientific model of causality. In: Stolzenberg RM, editor. Sociological Methodology. Vol 35. Boston (MA): Blackwell Publishing; 2005. p. 1-97
4. Schenk S. Sensitization as a process underlying the progression of drug use via gateway drugs. In: Kandel DB, editor. Stages and pathways of drug involvement: examining the gateway hypothesis. New York (NY): Cambridge University Press; 2002. p. 318-336.
5. Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G. Behavioral sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl) 2001; 158: 259-266.
6. Kandel DB, Yamaguchi K, Klein LC. Testing the gateway hypothesis. Addiction 2006; 101: 470-472.
7. Dahl RE, Spear LP, editors. Adolescent brain development vulnerabilities and opportunities. New York (NY): New York Academy of Sciences; 2004
8. Smith RF. Animal models of periadolescent substance abuse. Neurotoxicol Teratol 2003; 25: 291-301.
9. Levin ED, Rezvani AH, Montoya D, Rose JE, Swartzwelder HS. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology (Berl) 2003; 169: 141-149.
10. Klein LC. Effects of adolescent nicotine exposure on opioid consumption and neuroendocrine responses in adult male and female rats. Exp Clin Psychopharmacol 2001; 9: 251-261.
11. Agrawal A, Neale MC, Prescott CA, Kendler KS. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behav Genet 2004; 34: 217-228.
12. Pagan JL, Rose RJ, Viken RJ, Pulkkinen L, Kaprio J, Dick DM. Genetic and environmental influences on stages of alcohol use across adolescence and into young adulthood. Behav Genet 2006; 36: 483-497.
13. Agrawal A, Neale MC, Prescott CA, Kendler KS. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med 2004; 34: 1227-1237.
14. Lynskey MT, Heath AC, Bucholz KK, Slutske WS, Madden PA, Nelson EC, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003; 289: 427-433.
15. Shedler J, Block J. Adolescent drug use and psychological health: a longitudinal inquiry. Am Psychol 1990; 45: 612-630.
16. Aballkhail BA. Characteristics, nutritional and health status of addicts hospitalized for detoxification. Saudi Med J 1999; 20: 536-540.
17. Abdel-Mawgoud M, Fateem L, Al-Sharif AI. Development of a comprehensive treatment program for chemical dependency at Al-Amal hospital, Dammam. J Subst Abuse Treat 1995; 12: 369-376.
18. Al-Nahedh N. Relapse among substance-abuse patients in Riyadh, Saudi Arabia. East Mediterr Health J 1999; 5: 241-246.
19. Hafeiz HB. Sociodemographic correlates and pattern of drug abuse in eastern Saudi Arabia. Drug Alcohol Depend 1995; 38: 255-259.
20. Iqbal N. Substance dependence. A hospital-based survey. Saudi Med J 2000; 21: 51-57.
21. Qureshi NA. Sociodemographic correlates, pattern and comorbidity of drug abuse among psychiatric patients. Arab Journal of Psychiatry 1992; 2: 98-106.
22. Qureshi NA. Trihexyphenidyl (artane) abuse among Saudi psychiatric patients. Ann Saudi Med 1992; 12: 391-394.
23. Qureshi NA, Al-Amri AH, Beyari TH, Abdelgadir MH. Trihexyphenidyl dependence: a controlled investigation between users and misusers. Ann Saudi Med 1997; 17: 185-190.
24. Osman AA. Substance abuse among patients attending a psychiatric hospital in Jeddah: a descriptive study. Ann Saudi Med 1992; 12: 289-293.
25. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington (DC): American Psychiatric Press Inc; 1997.
26. Stata Corporation. STATA 6. Texas: Stata Corporation; 1999
27. Kandel DB, Davies M, Karus D, Yamaguchi K. The consequences in young adulthood of adolescent drug involvement. An overview. Arch Gen Psychiatry 1986; 43: 746-754.
28. Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 1992: 53: 447-457.
29. Kandel DB, Yamaguchi K. From beer to crack. Developmental patterns of drug involvement. Am J Public Health 1993; 83: 851-855.
30. Kandel DB, Logan JA. Patterns of drug use from adolescence to young adulthood: I. Periods of risk for initiation, continued use, and discontinuation. Am J Public Health 1984; 74: 660-666.
31. Anthony JC, Petronis KR. Early-onset drug use and risk of later drug problems. Drug Alcohol Depend 1995; 40: 9-15
32. Bates ME, Labouvie EW. Adolescent risk factors and the prediction of persistent alcohol and drug use into adulthood. Alcohol Clin Exp Res 1997; 21: 944-950.